$1M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
Although US stocks closed lower on Thursday, there were a few notable insider trades.
Truist Securities Maintains Buy on Cimpress, Lowers Price Target to $45
Truist Securities analyst Youssef Squali maintains Cimpress (NASDAQ:CMPR) with a Buy and lowers the price target from $85 to $45.
Cimpress Q2 Sales $845.20M Miss $901.00M Estimate
Cimpress (NASDAQ:CMPR) reported quarterly sales of $845.20 million which missed the analyst consensus estimate of $901.00 million by 6.19 percent. This is a 0.53 percent decrease over sales of $849.72 million the same
PVH, Five Below, Okta And Some Other Big Stocks Moving Higher On Thursday
U.S. stocks traded mostly lower, with the Dow Jones dropping over 300 points on Thursday. Here are some big stocks recording gains in today’s session.
Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday
Gainers
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) climbed 66.4% to close at $1.93 on Monday after the company announced an agreement with Janssen for the evaluation of three Sonnet product candidates.
Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday
Gainers
Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case.
Why Bank of America Shares Are Trading Higher? Here Are 66 Stocks Moving In Monday’s Mid-Day Session
Gainers
FedNat Holding Company (NASDAQ: FNHC) shares rose 78.9% to $0.93 after jumping 48% on Friday.
McCormick, Dave & Buster’s Entertainment And Other Big Losers From Thursday
U.S. stocks closed higher with the Dow Jones surging around 193 points on Thursday. Here is the list of some big stocks moving lower in the previous session.